Results 51 to 56 of about 58 (56)

L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case Report

JTO Clinical and Research Reports
D Ross Camidge
exaly  

Double molecular mimicry in Escherichia coli: binding of ribosomal protein L20 to its two sites in mRNA is similar to its binding to 23S rRNA

Molecular Microbiology, 2005
Frédéric Allemand, Frédéric Dardel, Catherine A Royer   +2 more
exaly  

CD74–ROS1 L2026M mutant enhances autophagy through the MEK / ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells

FEBS Journal
Xiaobo Xu, Zengqiang Li, Daiying Zuo
exaly  

Comprehensive Review of ROS1 Tyrosine Kinase Inhibitors-Classified by Structural Designs and Mutation Spectrum (Solvent Front Mutation [G2032R] and Central β-Sheet 6 [Cβ6] Mutation [L2086F])

Journal of Thoracic Oncology
Sai-Hong Ignatius Ou, Shannon S Zhang, Misako Nagasaka   +2 more
exaly  

Local and distal changes in dynamics are caused by an L205R Cushing’s syndrome mutant in PRKACA

Proceedings of the National Academy of Sciences of the United States of America
Alexandr P Kornev, Gianluigi Veglia, Rodrigo A Maillard   +2 more
exaly  

L'INSTITUT DE VACCINE ANIMALE, PARIS.

Lancet, The, 1905
exaly